Literature DB >> 2953751

Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.

N Ishikawa, K Eguchi, T Otsubo, Y Ueki, T Fukuda, H Tezuka, M Matsunaga, Y Kawabe, C Shimomura, M Izumi.   

Abstract

The expression of surface markers associated with activation and characterization was compared among T cells in thyroid glands and peripheral blood of 10 patients with Graves' hyperthyroidism receiving chronic antithyroid drug therapy, in peripheral blood of 15 patients with untreated hyperthyroid Graves' disease, and in peripheral blood of 21 normal subjects using two-color flow cytometry. In the chronically treated Graves' disease patients, the percentage of activated T cells (HLA-DR+ T cells) among total T cells was significantly higher in thyroid tissue than in peripheral blood, and the increase in percent activated T cells was also significant among both helper/inducer T cell (CD4+ cell) and suppressor/cytotoxic T cell (CD8+ cell) subsets. The percentage of activated T cells in peripheral blood was not significantly different between chronically treated hyperthyroid Graves' patients and normal subjects, whereas the percentage of activated T cells in the peripheral blood from untreated hyperthyroid Graves' disease patients was significantly higher than that in normal subjects or chronically treated hyperthyroid Graves' patients. The percentages of CD4+ cells and CD8+ cells among total T cells were not different between thyroid tissues and peripheral blood in patients with chronically treated hyperthyroid Graves' disease. When CD4+ were further divided into helper T cells (CD4+2H4- cells) and suppressor-inducer T cells (CD4+2H4+ cells) using two-color flow cytometry, the percentage of helper T cells among CD4+ cells was significantly higher in thyroid tissue than in peripheral blood, resulting in an increased ratio of CD4+2H4- cells to CD4+2H4+ cells. The percentage of CD4+2H4+ cells in peripheral blood, however, was not significantly different among untreated and chronically treated Graves' disease patients and normal subjects. From the findings of abnormalities in intrathyroidal T cell subsets, we suggest that the decrease in the function of suppressor T cells within the thyroids of Graves' disease patients may be due to a decrease in CD4+2H4+ cells within thyroid tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953751     DOI: 10.1210/jcem-65-1-17

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Serum-soluble interleukin-2 receptor levels before and after surgical treatment for Graves' disease.

Authors:  S Murakami; A Kobayashi; K Kuma; H Murai; Y Okamura; A Satomi; K Ishida
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 3.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

4.  Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.

Authors:  R Wilson; J H McKillop; C Pearson; A K Burnett; I Gunn; A M McNicol; J A Thomson
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 5.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

6.  Subacute panencephalitis associated with chronic graft-versus-host disease.

Authors:  Y Iwasaki; K Sako; Y Ohara; M Miyazawa; M Minegishi; S Tsuchiya; T Konno
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.

Authors:  Z Wu; E R Podack; J M McKenzie; K J Olsen; M Zakarija
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease.

Authors:  Y Iwatani; Y Hidaka; F Matsuzuka; K Kuma; N Amino
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.

Authors:  N Ishikawa; K Eguchi; Y Ueki; M Nakashima; H Shimada; K Ito; S Nagataki
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

10.  Immunological pattern in patients with 21-hydroxylase deficiency.

Authors:  F Parlato; G Pisano; M Brillante; R Ferrone; M R Cavalcanti; E Cosentini; G Misiano; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.